Delivery Order SPE2DB25D3005-SPE2DB25FQHML
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,970.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract was awarded on July 25, 2025, with an ultimate completion date of July 28, 2025, and carries firm fixed pricing with no set-aside designation. The award represents a competitively awarded delivery order under AmerisourceBergen's existing contract vehicle with DLA, reflecting the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,801.80 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens. This competitively awarded, firm fixed price delivery order was issued on August 1, 2025, with an ultimate completion date of August 4, 2025. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order reflects the company's continued capability to compete...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.65 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL quantity) on July 23, 2025. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 24, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in Conshohocken, PA. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,807.90 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion pharmaceutical supply vehicle running...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $1,772.87 with a completion date of July 31, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,304.68 to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pens on July 31, 2025, with completion targeted for August 1, 2025. This firm fixed-price, non-set-aside delivery order represents a purchase of pharmaceutical inventory to support military and federal healthcare needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the federal government...
- The Defense Logistics Agency awarded a delivery order valued at $1,377.09 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Trulicity 0.75 mg/0.5 mL pens. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,570.39 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order, which carries no set-aside designation, will be performed at the contractor's Conshohocken, Pennsylvania facility. As a child delivery order under a larger contract vehicle, this award represents a specific pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,370.70 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This firm fixed-price delivery order, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, carries no set-aside designation and represents a competitively awarded transaction. The pharmaceutical product will be delivered to the place of performance in Conshohocken,...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQHMLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,508.04 to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 mL pens on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed-price delivery order was awarded without set-aside restrictions through open competition and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, is supplying this diabetes medication as part of its broader portfolio of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a wide range of pharmaceutical products, medical supplies, specialty medications, vaccines, and associated commodities to support military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard. The delivery order reflects the company's established capability to fulfill federal pharmaceutical procurement requirements efficiently and competitively within DLA's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/1/25 |